|
Other Neuroleptics
Citations 201-210 of 280 total displayed.
|
Past content
(since Jan 1996):
|
- REGULAR ARTICLES
Improvement of Schizophrenic Patients With Primary Negative Symptoms Treated With Amisulpride
- Jean-Marie Danion, Werner Rein, Odile Fleurot, and the Amisulpride Study Group
Am J Psychiatry 1999; 156: 610-616.
[Abstract]
[Full text]
[PDF]
- BRIEF REPORTS
Sexual Disturbances During Clozapine and Haloperidol Treatment for Schizophrenia
- Martina Hummer, Georg Kemmler, Martin Kurz, Ilsemarie Kurzthaler, Harald Oberbauer, and W. Wolfgang Fleischhacker
Am J Psychiatry 1999; 156: 631-633.
[Abstract]
[Full text]
[PDF]
- BRIEF REPORTS
Increase in Expression of Adhesion Molecule Receptors on T Helper Cells During Antipsychotic Treatment and Relationship to Blood-Brain Barrier Permeability in Schizophrenia
- Norbert Müller, Michael Riedel, Myriam Hadjamu, Markus J. Schwarz, Manfred Ackenheil, and Rudolf Gruber
Am J Psychiatry 1999; 156: 634-636.
[Abstract]
[Full text]
[PDF]
- LETTERS TO THE EDITOR
Use of High-Dose Olanzapine in Refractory Psychosis
- JAMES REICH
Am J Psychiatry 1999; 156: 661.
[Full text]
[PDF]
- REGULAR ARTICLES
Comparative Effectiveness of Fluphenazine Decanoate Injections Every 2 Weeks Versus Every 6 Weeks
- William T. Carpenter, Jr., Robert W. Buchanan, Brian Kirkpatrick, Helen D. Lann, Alan F. Breier, and Ann T. Summerfelt
Am J Psychiatry 1999; 156: 412-418.
[Abstract]
[Full text]
[PDF]
- REGULAR ARTICLES
Placebo-Controlled Study of the D4/5-HT2A Antagonist Fananserin in the Treatment of Schizophrenia
- Philippe Truffinet, Carol A. Tamminga, Louis F. Fabre, Herbert Y. Meltzer, Marie-Emmanuelle Rivière, and Catherine Papillon-Downey
Am J Psychiatry 1999; 156: 419-425.
[Abstract]
[Full text]
[PDF]
- SPECIAL ARTICLES
Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome
- Ronald J. Gurrera
Am J Psychiatry 1999; 156: 169-180.
[Abstract]
[Full text]
[PDF]
- REGULAR ARTICLES
Clinical and Theoretical Implications of 5-HT2 and D2 Receptor Occupancy of Clozapine, Risperidone, and Olanzapine in Schizophrenia
- Shitij Kapur, Robert B. Zipursky, and Gary Remington
Am J Psychiatry 1999; 156: 286-293.
[Abstract]
[Full text]
[PDF]
- REGULAR ARTICLES
Clozapine and Risperidone in Chronic Schizophrenia: Effects on Symptoms, Parkinsonian Side Effects, and Neuroendocrine Response
- Alan F. Breier, Anil K. Malhotra, Tung-Ping Su, Debra A. Pinals, Igor Elman, Caleb M. Adler, R. Todd Lafargue, Allan Clifton, and David Pickar
Am J Psychiatry 1999; 156: 294-298.
[Abstract]
[Full text]
[PDF]
- REGULAR ARTICLES
Diazepam Treatment of Early Signs of Exacerbation in Schizophrenia
- William T. Carpenter, Jr., Robert W. Buchanan, Brian Kirkpatrick, and Alan F. Breier
Am J Psychiatry 1999; 156: 299-303.
[Abstract]
[Full text]
[PDF]
|
|